Global Prostate Cancer Diagnostics Market Growth 2021-2026

  • receipt Report ID : 238821
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Prostate Cancer Diagnostics will have significant change from previous year. By the most conservative estimates of global Prostate Cancer Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12250 million in 2020. Over the next five years the Prostate Cancer Diagnostics market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 16400 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnostics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Tumor Biomarker Tests

Imaging

Biopsy

Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

age Below 55

age 55-75

age Above 75

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Genomic Health

Abbott

OPKO

Siemens Healthcare

DiaSorin

BioMeriux

Roche

MDx Health

Beckman Coulter

Myriad Genetics

Ambry Genetics

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Cancer Diagnostics Consumption 2016-2026

2.1.2 Prostate Cancer Diagnostics Consumption CAGR by Region

2.2 Prostate Cancer Diagnostics Segment by Type

2.2.1 Tumor Biomarker Tests

2.2.2 Imaging

2.2.3 Biopsy

2.2.4 Other

2.3 Prostate Cancer Diagnostics Sales by Type

2.3.1 Global Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)

2.3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2016-2021)

2.3.3 Global Prostate Cancer Diagnostics Sale Price by Type (2016-2021)

2.4 Prostate Cancer Diagnostics Segment by Application

2.4.1 age Below 55

2.4.2 age 55-75

2.4.3 age Above 75

2.5 Prostate Cancer Diagnostics Sales by Application

2.5.1 Global Prostate Cancer Diagnostics Sale Market Share by Application (2016-2021)

2.5.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Application (2016-2021)

2.5.3 Global Prostate Cancer Diagnostics Sale Price by Application (2016-2021)

3 Global Prostate Cancer Diagnostics by Company

3.1 Global Prostate Cancer Diagnostics Sales Market Share by Company

3.1.1 Global Prostate Cancer Diagnostics Sales by Company (2019-2021)

3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Company (2019-2021)

3.2 Global Prostate Cancer Diagnostics Revenue Market Share by Company

3.2.1 Global Prostate Cancer Diagnostics Revenue by Company (2019-2021)

3.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Company (2019-2021)

3.3 Global Prostate Cancer Diagnostics Sale Price by Company

3.4 Global Manufacturers Prostate Cancer Diagnostics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prostate Cancer Diagnostics Product Location Distribution

3.4.2 Players Prostate Cancer Diagnostics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Prostate Cancer Diagnostics by Region

4.1 Global Prostate Cancer Diagnostics by Region

4.1.1 Global Prostate Cancer Diagnostics Sales by Region

4.1.2 Global Prostate Cancer Diagnostics Revenue by Region

4.2 Americas Prostate Cancer Diagnostics Sales Growth

4.3 APAC Prostate Cancer Diagnostics Sales Growth

4.4 Europe Prostate Cancer Diagnostics Sales Growth

4.5 Middle East & Africa Prostate Cancer Diagnostics Sales Growth

5 Americas

5.1 Americas Prostate Cancer Diagnostics Sales by Country

5.1.1 Americas Prostate Cancer Diagnostics Sales by Country (2016-2021)

5.1.2 Americas Prostate Cancer Diagnostics Revenue by Country (2016-2021)

5.2 Americas Prostate Cancer Diagnostics Sales by Type

5.3 Americas Prostate Cancer Diagnostics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Diagnostics Sales by Region

6.1.1 APAC Prostate Cancer Diagnostics Sales by Region (2016-2021)

6.1.2 APAC Prostate Cancer Diagnostics Revenue by Region (2016-2021)

6.2 APAC Prostate Cancer Diagnostics Sales by Type

6.3 APAC Prostate Cancer Diagnostics Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Prostate Cancer Diagnostics by Country

7.1.1 Europe Prostate Cancer Diagnostics Sales by Country (2016-2021)

7.1.2 Europe Prostate Cancer Diagnostics Revenue by Country (2016-2021)

7.2 Europe Prostate Cancer Diagnostics Sales by Type

7.3 Europe Prostate Cancer Diagnostics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Cancer Diagnostics by Country

8.1.1 Middle East & Africa Prostate Cancer Diagnostics Sales by Country (2016-2021)

8.1.2 Middle East & Africa Prostate Cancer Diagnostics Revenue by Country (2016-2021)

8.2 Middle East & Africa Prostate Cancer Diagnostics Sales by Type

8.3 Middle East & Africa Prostate Cancer Diagnostics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Prostate Cancer Diagnostics Distributors

10.3 Prostate Cancer Diagnostics Customer

11 Global Prostate Cancer Diagnostics Market Forecast

11.1 Global Prostate Cancer Diagnostics Forecast by Region

11.1.1 Global Prostate Cancer Diagnostics Forecast by Regions (2021-2026)

11.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Prostate Cancer Diagnostics Forecast by Type

11.7 Global Prostate Cancer Diagnostics Forecast by Application

12 Key Players Analysis

12.1 Genomic Health

12.1.1 Genomic Health Company Information

12.1.2 Genomic Health Prostate Cancer Diagnostics Product Offered

12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Genomic Health Main Business Overview

12.1.5 Genomic Health Latest Developments

12.2 Abbott

12.2.1 Abbott Company Information

12.2.2 Abbott Prostate Cancer Diagnostics Product Offered

12.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Abbott Main Business Overview

12.2.5 Abbott Latest Developments

12.3 OPKO

12.3.1 OPKO Company Information

12.3.2 OPKO Prostate Cancer Diagnostics Product Offered

12.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 OPKO Main Business Overview

12.3.5 OPKO Latest Developments

12.4 Siemens Healthcare

12.4.1 Siemens Healthcare Company Information

12.4.2 Siemens Healthcare Prostate Cancer Diagnostics Product Offered

12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Siemens Healthcare Main Business Overview

12.4.5 Siemens Healthcare Latest Developments

12.5 DiaSorin

12.5.1 DiaSorin Company Information

12.5.2 DiaSorin Prostate Cancer Diagnostics Product Offered

12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 DiaSorin Main Business Overview

12.5.5 DiaSorin Latest Developments

12.6 BioMeriux

12.6.1 BioMeriux Company Information

12.6.2 BioMeriux Prostate Cancer Diagnostics Product Offered

12.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 BioMeriux Main Business Overview

12.6.5 BioMeriux Latest Developments

12.7 Roche

12.7.1 Roche Company Information

12.7.2 Roche Prostate Cancer Diagnostics Product Offered

12.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Roche Main Business Overview

12.7.5 Roche Latest Developments

12.8 MDx Health

12.8.1 MDx Health Company Information

12.8.2 MDx Health Prostate Cancer Diagnostics Product Offered

12.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 MDx Health Main Business Overview

12.8.5 MDx Health Latest Developments

12.9 Beckman Coulter

12.9.1 Beckman Coulter Company Information

12.9.2 Beckman Coulter Prostate Cancer Diagnostics Product Offered

12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Beckman Coulter Main Business Overview

12.9.5 Beckman Coulter Latest Developments

12.10 Myriad Genetics

12.10.1 Myriad Genetics Company Information

12.10.2 Myriad Genetics Prostate Cancer Diagnostics Product Offered

12.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Myriad Genetics Main Business Overview

12.10.5 Myriad Genetics Latest Developments

12.11 Ambry Genetics

12.11.1 Ambry Genetics Company Information

12.11.2 Ambry Genetics Prostate Cancer Diagnostics Product Offered

12.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Ambry Genetics Main Business Overview

12.11.5 Ambry Genetics Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Prostate Cancer Diagnostics Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Tumor Biomarker Tests

Table 3. Major Players of Imaging

Table 4. Major Players of Biopsy

Table 5. Major Players of Other

Table 6. Global Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)

Table 7. Global Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)

Table 8. Global Prostate Cancer Diagnostics Revenue by Type (2016-2021) & ($ million)

Table 9. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2021)

Table 10. Global Prostate Cancer Diagnostics Sale Price by Type (2016-2021)

Table 11. Global Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)

Table 12. Global Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)

Table 13. Global Prostate Cancer Diagnostics Value by Application (2016-2021)

Table 14. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2021)

Table 15. Global Prostate Cancer Diagnostics Sale Price by Application (2016-2021)

Table 16. Global Prostate Cancer Diagnostics Sales by Company (2019-2021) & (K Units)

Table 17. Global Prostate Cancer Diagnostics Sales Market Share by Company (2019-2021)

Table 18. Global Prostate Cancer Diagnostics Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2019-2021)

Table 20. Global Prostate Cancer Diagnostics Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Prostate Cancer Diagnostics Producing Area Distribution and Sales Area

Table 22. Players Prostate Cancer Diagnostics Products Offered

Table 23. Prostate Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Prostate Cancer Diagnostics Sales by Region (2016-2021) (K Units)

Table 27. Global Prostate Cancer Diagnostics Sales Market Share by Region (2016-2021)

Table 28. Global Prostate Cancer Diagnostics Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2016-2021)

Table 30. Americas Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)

Table 31. Americas Prostate Cancer Diagnostics Sales Market Share by Country (2016-2021)

Table 32. Americas Prostate Cancer Diagnostics Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2021)

Table 34. Americas Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)

Table 35. Americas Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)

Table 36. Americas Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)

Table 37. Americas Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)

Table 38. APAC Prostate Cancer Diagnostics Sales by Region (2016-2021) & (K Units)

Table 39. APAC Prostate Cancer Diagnostics Sales Market Share by Region (2016-2021)

Table 40. APAC Prostate Cancer Diagnostics Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Prostate Cancer Diagnostics Revenue Market Share by Region (2016-2021)

Table 42. APAC Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)

Table 43. APAC Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)

Table 44. APAC Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)

Table 45. APAC Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)

Table 46. Europe Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)

Table 47. Europe Prostate Cancer Diagnostics Sales Market Share by Country (2016-2021)

Table 48. Europe Prostate Cancer Diagnostics Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2021)

Table 50. Europe Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)

Table 51. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)

Table 52. Europe Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)

Table 53. Europe Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)

Table 55. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Prostate Cancer Diagnostics Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)

Table 59. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)

Table 61. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Prostate Cancer Diagnostics

Table 63. Key Application and Potential Industries of Prostate Cancer Diagnostics

Table 64. Key Challenges of Prostate Cancer Diagnostics

Table 65. Key Trends of Prostate Cancer Diagnostics

Table 66. Prostate Cancer Diagnostics Distributors List

Table 67. Prostate Cancer Diagnostics Customer List

Table 68. Global Prostate Cancer Diagnostics Sales Forecast by Region (2021-2026) & (K Units)

Table 69. Global Prostate Cancer Diagnostics Consumption Market Forecast by Region

Table 70. Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Prostate Cancer Diagnostics Sales Forecast by Country (2021-2026) & (K Units)

Table 73. Americas Prostate Cancer Diagnostics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Prostate Cancer Diagnostics Sales Forecast by Region (2021-2026) & (K Units)

Table 75. APAC Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Prostate Cancer Diagnostics Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Europe Prostate Cancer Diagnostics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Prostate Cancer Diagnostics Sales Forecast by Country (2021-2026) & (K Units)

Table 79. Middle East & Africa Prostate Cancer Diagnostics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026) & (K Units)

Table 81. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026) & (K Units)

Table 85. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Application (2021-2026)

Table 88. Genomic Health Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 89. Genomic Health Prostate Cancer Diagnostics Product Offered

Table 90. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 91. Genomic Health Main Business

Table 92. Genomic Health Latest Developments

Table 93. Abbott Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 94. Abbott Prostate Cancer Diagnostics Product Offered

Table 95. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 96. Abbott Main Business

Table 97. Abbott Latest Developments

Table 98. OPKO Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 99. OPKO Prostate Cancer Diagnostics Product Offered

Table 100. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 101. OPKO Main Business

Table 102. OPKO Latest Developments

Table 103. Siemens Healthcare Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 104. Siemens Healthcare Prostate Cancer Diagnostics Product Offered

Table 105. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 106. Siemens Healthcare Main Business

Table 107. Siemens Healthcare Latest Developments

Table 108. DiaSorin Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 109. DiaSorin Prostate Cancer Diagnostics Product Offered

Table 110. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 111. DiaSorin Main Business

Table 112. DiaSorin Latest Developments

Table 113. BioMeriux Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 114. BioMeriux Prostate Cancer Diagnostics Product Offered

Table 115. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 116. BioMeriux Main Business

Table 117. BioMeriux Latest Developments

Table 118. Roche Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 119. Roche Prostate Cancer Diagnostics Product Offered

Table 120. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 121. Roche Main Business

Table 122. Roche Latest Developments

Table 123. MDx Health Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 124. MDx Health Prostate Cancer Diagnostics Product Offered

Table 125. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 126. MDx Health Main Business

Table 127. MDx Health Latest Developments

Table 128. Beckman Coulter Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 129. Beckman Coulter Prostate Cancer Diagnostics Product Offered

Table 130. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 131. Beckman Coulter Main Business

Table 132. Beckman Coulter Latest Developments

Table 133. Myriad Genetics Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 134. Myriad Genetics Prostate Cancer Diagnostics Product Offered

Table 135. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 136. Myriad Genetics Main Business

Table 137. Myriad Genetics Latest Developments

Table 138. Ambry Genetics Basic Information, Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors

Table 139. Ambry Genetics Prostate Cancer Diagnostics Product Offered

Table 140. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 141. Ambry Genetics Main Business

Table 142. Ambry Genetics Latest Developments

List of Figures

Figure 1. Picture of Prostate Cancer Diagnostics

Figure 2. Prostate Cancer Diagnostics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prostate Cancer Diagnostics Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Prostate Cancer Diagnostics Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Prostate Cancer Diagnostics Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Tumor Biomarker Tests

Figure 10. Product Picture of Imaging

Figure 11. Product Picture of Biopsy

Figure 12. Product Picture of Other

Figure 13. Global Prostate Cancer Diagnostics Sales Market Share by Type in 2020

Figure 14. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2021)

Figure 15. Prostate Cancer Diagnostics Consumed in age Below 55

Figure 16. Global Prostate Cancer Diagnostics Market: age Below 55 (2016-2021) & (K Units)

Figure 17. Prostate Cancer Diagnostics Consumed in age 55-75

Figure 18. Global Prostate Cancer Diagnostics Market: age 55-75 (2016-2021) & (K Units)

Figure 19. Prostate Cancer Diagnostics Consumed in age Above 75

Figure 20. Global Prostate Cancer Diagnostics Market: age Above 75 (2016-2021) & (K Units)

Figure 21. Global Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)

Figure 22. Global Prostate Cancer Diagnostics Revenue Market Share by Application in 2020

Figure 23. Prostate Cancer Diagnostics Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Prostate Cancer Diagnostics Revenue Market Share by Company in 2020

Figure 25. Global Prostate Cancer Diagnostics Sales Market Share by Regions (2016-2021)

Figure 26. Global Prostate Cancer Diagnostics Revenue Market Share by Region in 2020

Figure 27. Americas Prostate Cancer Diagnostics Sales 2016-2021 (K Units)

Figure 28. Americas Prostate Cancer Diagnostics Revenue 2016-2021 ($ Millions)

Figure 29. APAC Prostate Cancer Diagnostics Sales 2016-2021 (K Units)

Figure 30. APAC Prostate Cancer Diagnostics Revenue 2016-2021 ($ Millions)

Figure 31. Europe Prostate Cancer Diagnostics Sales 2016-2021 (K Units)

Figure 32. Europe Prostate Cancer Diagnostics Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Prostate Cancer Diagnostics Sales 2016-2021 (K Units)

Figure 34. Middle East & Africa Prostate Cancer Diagnostics Revenue 2016-2021 ($ Millions)

Figure 35. Americas Prostate Cancer Diagnostics Sales Market Share by Country in 2020

Figure 36. Americas Prostate Cancer Diagnostics Revenue Market Share by Country in 2020

Figure 37. Americas Prostate Cancer Diagnostics Sales Market Share by Type in 2020

Figure 38. Americas Prostate Cancer Diagnostics Sales Market Share by Application in 2020

Figure 39. United States Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Prostate Cancer Diagnostics Sales Market Share by Region in 2020

Figure 44. APAC Prostate Cancer Diagnostics Revenue Market Share by Regions in 2020

Figure 45. APAC Prostate Cancer Diagnostics Sales Market Share by Type in 2020

Figure 46. APAC Prostate Cancer Diagnostics Sales Market Share by Application in 2020

Figure 47. China Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Prostate Cancer Diagnostics Sales Market Share by Country in 2020

Figure 54. Europe Prostate Cancer Diagnostics Revenue Market Share by Country in 2020

Figure 55. Europe Prostate Cancer Diagnostics Sales Market Share by Type in 2020

Figure 56. Europe Prostate Cancer Diagnostics Sales Market Share by Application in 2020

Figure 57. Germany Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Prostate Cancer Diagnostics Sales Market Share by Application in 2020

Figure 66. Egypt Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Prostate Cancer Diagnostics Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery